7,119
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Legacy and emerging per- and polyfluoroalkyl substances suppress the neutrophil respiratory burst

ORCID Icon, , ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2176953 | Received 09 Nov 2022, Accepted 01 Feb 2023, Published online: 14 Feb 2023

References

  • Agency for Toxic Substances and Disease Registry (ATSDR). 2021. Toxicological Profile for Perfluoroalkyls. Atlanta, GA:U.S. Department of Health and Human Services.
  • Ahrens L, Barber J, Xie Z, Ebinghaus R. 2009. Longitudinal and latitudinal distribution of perfluoroalkyl compounds in the surface water of the Atlantic Ocean. Environ Sci Technol. 43(9):3122–3127.
  • Ait Bamai Y, Goudarzi H, Araki A, Okada E, Kashino I, Miyashita C, Kishi R. 2020. Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The Hokkaido study on Environment and Children’s Health. Environ. Intl. 143:105979.
  • Andrews D, Naidenko O. 2020. Population-wide exposure to per- and polyfluoroalkyl substances from drinking water in the United States. Environ Sci Technol Lett. 7(12):931–936.
  • Averina M, Brox J, Huber S, Furberg A-S, Sørensen M. 2019. Serum perfluoroalkyl substances (PFAS) and risk of asthma and various allergies in adolescents. The Tromsø study fit futures in northern Norway. Environ Res. 169:114–121.
  • Bangma J, Szilagyi J, Blake B, Plazas C, Kepper S, Fenton SC, Fry R. 2020. An assessment of serum-dependent impacts on intracellular accumulation and genomic response of per- and polyfluoroalkyl substances in a placental trophoblast model. Environ. Toxicol. 35(12):1395–1405.
  • Behr A, Lichtenstein D, Braeuning A, Lampen A, Buhrke T. 2018. Perfluoroalkylated substances (PFAS) affect neither estrogen and androgen receptor activity nor steroidogenesis in human cells in vitro. Toxicol. Lett. 291:51–60.
  • Behr A, Plinsch C, Braeuning A, Buhrke T. 2020. Activation of human nuclear receptors by perfluoroalkylated substances (PFAS). Toxicol in Vitro. 62:104700.
  • Berntsen H, Bodin J, Øvrevik J, Berntsen C, Østby G, Brinchmann B, Ropstad E, Myhre O. 2022. A human-relevant mixture of persistent organic pollutants induces reactive oxygen species formation in isolated human leucocytes: Involvement of the β2-adrenergic receptor. Environ Intl. 158:106900.
  • Berntsen H, Bolling A, Bjorklund C, Zimmer K, Ropstad E, Zienolddiny S, Becher R, Holme J, Dirven H, Nygaard U, et al. 2018. Decreased macrophage phagocytic function due to xenobiotic exposures in vitro, difference in sensitivity between various macrophage models. Food Chem Toxicol. 112:86–96.
  • Blanter M, Gouwy M, Struyf S. 2021. Studying neutrophil function in vitro: Cell models and environmental factors. JIR. 14:141–162.
  • Brach M, Brach M, deVos S, Gruss H, Herrmann F. 1992. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood. 80(11):2920–2924.
  • Brieger A, Bienefeld N, Hasan R, Goerlich R, Haase H. 2011. Impact of perfluorooctanesulfon-ate and perfluorooctanoic acid on human peripheral leukocytes. Toxicol in Vitro. 25(4):960–968.
  • Brown S, Flynn R, Hoverman J. 2021. Perfluoroalkyl substances increase susceptibility of northern leopard frog tadpoles to trematode infection. Environ Toxicol Chem. 40(3):689–694.
  • Buck R, Franklin J, Berger U, Conder J, Cousins I, de Voogt P, Jensen A, Kannan K, Mabury S, van Leeuwen S. 2011. Perfluoroalkyl and polyfluoroalkyl substances in the environment: Terminology, classification, and origins. Integr Environ Assess Manag. 7(4):513–541.
  • Buser M, Scinicariello F. 2016. Perfluoroalkyl substances and food allergies in adolescents. Environ Intl. 88:74–79.
  • Calafat A, Wong L, Kuklenyik Z, Reidy J, Needham L. 2007. Polyfluoroalkyl chemicals in the U.S. population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000. Environ Health Perspect. 115(11):1596–1602.
  • Centers for Disease Control and Prevention (CDC). 2019. National Report on Human Exposure to Environmental Chemicals. U.S. Department of Health and Human Services. (March 2022 Update). Atlanta, GA:U.S. Department of Health & Human Services.
  • Conder J, Hoke R, de Wolf W, Russell M, Buck R. 2008. Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds. Environ Sci Technol. 42(4):995–1003.
  • Conley J, Lambright C, Evans N, Medlock-Kakaley E, Hill D, McCord J, Strynar M, Wehmas L, Hester S, MacMillan D, et al. 2022. Developmental toxicity of Nafion byproduct 2 (NBP2) in the Sprague-Dawley rat with comparisons to hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) and perfluorooctane sulfonate (PFOS). Environ Intl. 160:107056.
  • Dahlgren C, Karlsson A, Bylund J. 2019. Intracellular neutrophil oxidants: From laboratory curiosity to clinical reality. J Immunol. 202(11):3127–3134.
  • Dalsager L, Christensen N, Husby S, Kyhl H, Nielsen F, Host A, Grandjean P, Jensen T. 2016. Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1-4years among 359 children in the Odense Child Cohort. Environ Intl. 96:58–64.
  • De Guise S, Levin M. 2021. Suppression of TH2 cytokines as a potential mechanism for reduced antibody response following PFOA exposure in female B6C3F1 mice. Toxicol Lett. 351:155–162.
  • DeWitt J, Blossom S, Schaider L. 2019. Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: Epidemiological and toxicological evidence. J Expo Sci Environ Epidemiol. 29(2):148–156.
  • DeWitt J, Copeland C, Luebke R. 2009. Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice. Toxicol Sci. 109(1):106–112.
  • DeWitt J, Copeland C, Strynar M, Luebke R. 2008. Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice. Environ Health Perspect. 116(5):644–650.
  • DeWitt J, Williams W, Creech N, Luebke R. 2016. Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARα and T- and B-cell targeting. J Immunotoxicol. 13(1):38–45.
  • Dong G, Liu M, Wang D, Zheng L, Liang Z, Jin Y. 2011. Sub-chronic effect of perfluoro-octanesulfonate (PFOS) on the balance of Type 1 and Type 2 cytokine in adult C57BL6 mice. Arch Toxicol. 85(10):1235–1244.
  • Dong G, Zhang Y, Zheng L, Liang Z, Jin Y, He Q. 2012. Subchronic effects of perfluoro-octanesulfonate exposure on inflammation in adult male C57BL/6 mice. Environ Toxicol. 27(5):285–296.
  • Dong G, Zhang Y, Zheng L, Liu W, Jin Y, He Q. 2009. Chronic effects of perfluoro-octanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice. Arch Toxicol. 83(9):805–815.
  • Drutman S, Mansouri D, Mahdaviani S, Neehus A, Hum D, Bryk R, Hernandez N, Belkaya S, Rapaport F, Bigio B, et al. 2020. Fatal cytomegalovirus infection in an adult with inherited NOS2 deficiency. N Engl J Med. 382(5):437–445.
  • Dupré-Crochet S, Erard M, Nüβe O. 2013. ROS production in phagocytes: Why, when, and where? J Leukoc Biol. 94(4):657–670.
  • Environmental Protection Agency (EPA). 2020. PFAS Master List of PFAS Substances. EPA CompTox Chemicals Dashboard. [accessed 2022 Jan 25]. https://comptox.epa.gov/ dashboard/chemical-lists/PFASMASTER.
  • Evich M, Davis M, McCord J, Acrey B, Awkerman J, Knappe D, Lindstrom A, Speth T, Tebes-Stevens C, Strynar M, et al. 2022. Per- and polyfluoroalkyl substances in the environment. Science. 375(6580):eabg9065.
  • Fenton S, Ducatman A, Boobis A, DeWitt J, Lau C, Ng C, Smith J, Roberts S. 2021. Per- and polyfluoroalkyl substance toxicity and human health review: Current state of knowledge and strategies for informing future research. Environ Toxicol Chem. 40(3):606–630.
  • Fingerhut L, Dolz G, de Buhr N. 2020. What is the evolutionary fingerprint in neutrophil granulocytes? IJMS. 21(12):4523.
  • Fitzgerald N, Wargenau A, Sorenson C, Pedersen J, Tufenkji N, Novak P, Simcik M. 2018. Partitioning and accumulation of perfluoroalkyl substances in model lipid bilayers and bacteria. Environ Sci Technol. 52(18):10433–10440.
  • Gaballah S, Swank A, Sobus JR, Howey X, Schmid J, Catron T, McCord J, Hines E, Strynar M, Tal T. 2020. Evaluation of developmental toxicity, developmental neurotoxicity, and tissue dose in zebrafish exposed to GenX and other PFAS. Environ Health Perspect. 128(4):47005.
  • Gallagher R, Collins S, Trujillo J, McCredie K, Ahearn M, Tsai S, Metzgar R, Aulakh G, Ting R, Ruscetti F, et al. 1979. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 54(3):713–733.
  • Gebreab K, Eeza M, Bai T, Zuberi Z, Matysik J, O’Shea K, Alia A, Berry J. 2020. Comparative toxico-metabolomics of perfluorooctanoic acid (PFOA) and next-generation perfluoroalkyl substances. Environ Pollut. 265:114928.
  • Goudarzi H, Miyashita C, Okada E, Kashino I, Chen C, Ito S, Araki A, Kobayashi S, Matsuura H, Kishi R. 2017. Prenatal exposure to perfluoroalkyl acids and prevalence of infectious diseases up to 4 years of age. Environ Intl. 104:132–138.
  • Grandjean P, Heilmann C, Weihe P, Nielsen F, Mogensen U, Budtz-Jorgensen E. 2017a. Serum vaccine antibody concentrations in adolescents exposed to perfluorinated compounds. Environ Health Perspect. 125(7):077018.
  • Grandjean P, Heilmann C, Weihe P, Nielsen F, Mogensen U, Timmermann A, Budtz-Jorgensen E. 2017b. Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years. J Immunotoxicol. 14(1):188–195.
  • Grandjean P, Timmermann C, Kruse M, Nielsen F, Vinholt P, Boding L, Heilmann C, Mølbak K. 2020. Severity of COVID-19 at elevated exposure to perfluorinated alkylates. PLOS One. 15(12):e0244815.
  • Guruge K, Hikono H, Shimada N, Murakami K, Hasegawa J, Yeung L, Yamanaka N, Yamashita N. 2009. Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice. J Toxicol Sci. 34(6):687–691.
  • Herb M, Schramm M. 2021. Functions of ROS in macrophages and anti-microbial immunity. Antioxidants . 10(2):313.
  • Howe K, Clark M, Torroja C, Torrance J, Berthelot C, Muffato M, Collins J, Humphray S, McLaren K, Matthews L, et al. 2013. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 496(7446):498–503.
  • Humblet O, Diaz-Ramirez L, Balmes J, Pinney S, Hiatt R. 2014. Perfluoroalkyl chemicals and asthma among children 12–19 years of age: NHANES (1999–2008). Environ Health Perspect. 122(10):1129–1133.
  • Hu X, Andrews D, Lindstrom A, Bruton T, Schaider L, Grandjean P, Lohmann R, Carignan C, Blum A, Balan S, et al. 2016. Detection of poly- and perfluoroalkyl substances (PFASs) in U.S. drinking water linked to industrial sites, military fire training areas, and wastewater treatment plants. Environ Sci Technol Lett. 3(10):344–350.
  • Hyötyläinen T, Bodin J, Duberg D, Dirven H, Nygaard U, Orešič M. 2021. Lipidomic analyses reveal modulation of lipid metabolism by the PFAS perfluoroundecanoic acid (PFUnDA) in non-obese diabetic mice. Front Genet. 12:721507.
  • Impinen A, Nygaard U, Lødrup Carlsen K, Mowinckel P, Carlsen K, Haug L, Granum B. 2018. Prenatal exposure to perfluoralkyl substances (PFASs) associated with respiratory tract infections but not allergy- and asthma-related health outcomes in childhood. Environ Res. 160:518–523.
  • Jabeen M, Fayyaz M, Irudayaraj J. 2020. Epigenetic modifications, and alterations in cell cycle and apoptosis pathway in A549 lung carcinoma cell line upon exposure to perfluoroalkyl substances. Toxics. 8(4):112.
  • Karlsson J, von Hofsten J, Olsson P. 2001. Generating transparent zebrafish: A refined method to improve detection of gene expression during embryonic development. Mar Biotechnol. 3(6):522–527.
  • Karlsson T, Glogauer M, Ellen R, Loitto V, Magnusson K, Magalhães M. 2011. Aquaporin 9 phosphorylation mediates membrane localization and neutrophil polarization. J Leukoc Biol. 90(5):963–973.
  • Keil D, Mehlmann T, Butterworth L, Peden-Adams M. 2008. Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. Toxicol Sci. 103(1):77–85.
  • Kim S, Thapar I, Brooks B. 2021. Epigenetic changes by per- and polyfluoroalkyl substances (PFAS). Environ Pollut. 279:116929.
  • King M, Radicchi-Mastroianni M. 2002. Effects of caspase inhibition on camptothecin-induced apoptosis of HL-60 cells. Cytometry. 49(1):28–35.
  • Klebanoff S. 1970. Myeloperoxidase: Contribution to the microbicidal activity of intact leukocytes. Science. 169(3950):1095–1097.
  • Kotlarz N, McCord J, Collier D, Lea CS, Strynar M, Lindstrom A, Wilkie A, Islam J, Matney K, Tarte P, et al. 2020. Measurement of novel, drinking water-associated PFAS in blood from adults and children in Wilmington, North Carolina. Environ Health Perspect. 128(7):77005.
  • Kvalem H, Nygaard U, Lødrup Carlsen K, Carlsen K, Haug L, Granum B. 2020. Perfluoroalkyl substances, airways infections, allergy, and asthma related health outcomes – implications of gender, exposure period and study design. Environ Intl. 134:105259.
  • Lang J, Strynar M, Lindstrom A, Farthing A, Huang H, Schmid J, Hill D, Chernoff N. 2020. Toxicity of Balb/c mice exposed to recently identified 1,1,2,2-tetrafluoro-2-[1,1,1,2,3,3-hexafluoro-3-(1,1,2,2-tetrafluoroethoxy)propan-2-yl]oxyethane-1-sulfonic acid (PFESA-BP2). Toxicology. 441:152529.
  • Le Guyader D, Redd M, Colucci-Guyon E, Murayama E, Kissa K, Briolat V, Mordelet E, Zapata A, Shinomiya H, Herbomel P. 2008. Origins and unconventional behavior of neutrophils in developing zebrafish. Blood. 111(1):132–141.
  • Liang L, Pan Y, Bin L, Liu Y, Huang W, Li R, Lai K. 2022. Immunotoxicity mechanisms of perfluorinated compounds PFOA and PFOS. Chemosphere. 291(Pt 2):132892.
  • Liberatore H, Jackson S, Strynar M, McCord JP. 2020. Solvent suitability for HFPO-DA (“GenX” parent acid) in toxicological studies. Environ Sci Technol Lett. 7(7):477–481.
  • Manara S, Chin J, Schneider D. 1991. Role of degranulation in activation of the respiratory burst in human neutrophils. J Leukoc Biol. 49(5):489–498.
  • Martin E, Till R, Sheats M, Jones S. 2017. Misoprostol Inhibits equine neutrophil adhesion, migration, and respiratory burst in an in vitro model of inflammation. Front Vet Sci. 4:159.
  • Marvel S, To K, Grimm F, Wright F, Rusyn I, Reif D. 2018. ToxPi Graphical User Interface 2.0: Dynamic exploration, visualization, and sharing of integrated data models. BMC Bioinf. 19(1):80.
  • Midgett K, Peden-Adams M, Gilkeson G, Kamen D. 2015. In vitro evaluation of the effects of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) on IL-2 production in human T-cells. J Appl Toxicol. 35(5):459–465.
  • Mylroie J, Wilbanks M, Kimble A, To K, Cox C, McLeod S, Gust K, Moore D, Perkins E, Garcia-Reyero N. 2021. Perfluorooctanesulfonic acid-induced toxicity on zebrafish embryos in the presence or absence of the chorion. Environ Toxicol Chem. 40(3):780–791.
  • Naidenko O, Andrews DQ, Temkin AM, Stoiber T, Uche UI, Evans S, Perrone-Gray S. 2021. Investigating molecular mechanisms of immunotoxicity and the utility of ToxCast for immunotoxicity screening of chemicals added to food. IJERPH. 18(7):3332.
  • National Toxicology Program (NTP). 2016. Monograph on Immunotoxicity Associated with Exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). Research Triangle Park, NC: U.S. Department of Health and Human Services.
  • National Toxicology Program (NTP). 2020. NTP technical report on the toxicology and carcinogenesis studies of perfluorooctanoic acid (CASRN 335-67-1) administered in feed to Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats. Research Triangle Park, NC: U.S. Department of Health and Human Services.
  • Neagu M, Constantin C, Bardi G, Duraes L. 2021. Adverse outcome pathway in immunotoxicity of perfluoroalkyls. Curr Opin Toxicol. 25:23–29.
  • Neehus A, Moriya K, Nieto-Patlán A, Le Voyer T, Lévy R, Özen A, Karakoc-Aydiner E, Baris S, Yildiran A, Altundag E, et al. 2021. Impaired respiratory burst contributes to infections in PKCδ-deficient patients. J Exp Med. 218:e20210501.
  • Neehus A, Tuano K, Le Voyer T, Nandiwada S, Murthy K, Puel A, Casanova JL, Chinen J, Bustamante J. 2022. Chronic granulomatous disease-like presentation of a child with autosomal recessive PKCδ deficiency. J Clin Immunol. 42(6):1244–1253.
  • Ng C, Hungerbühler K. 2014. Bioaccumulation of perfluorinated alkyl acids: Observations and models. Environ Sci Technol. 48(9):4637–4648.
  • Nouhi S, Ahrens L, Campos Pereira H, Hughes A, Campana M, Gutfreund P, Palsson G, Vorobiev A, Hellsing M. 2018. Interactions of perfluoroalkyl substances with a phospholipid bilayer studied by neutron reflectometry. J Colloid Interface Sci. 511:474–481.
  • Office of Prevention, Pesticides, and Toxic Substances (OPPTS). 1998. Health Effects Test Guidelines OPPTS 870.7800 Immunotoxicity. Research Triangle Park, NC: U.S. Environmental Protection Agency.
  • Organization for Economic Cooperation and Development (OECD). 2018. Environment Directorate Joint Meeting of the Chemicals Committee and the Working Party on Chemicals, Pesticides and Biotechnology. Toward a new comprehensive global database of per- and polyfluoroalkyl substances (PFASs): Summary report on updating the OECD 2007 list of per- and polyfluoroalkyl substances (PFASs). Series on Risk Management #39. Paris, France: Inter-Organization Program for Sound Management of Chemicals (IOMC).
  • Peden-Adams M, EuDaly J, Dabra S, EuDaly A, Heesemann L, Smythe J, Keil D. 2007. Suppression of humoral immunity following exposure to the perfluorinated insecticide sulfluramid. J Toxicol Environ Health. 70(13):1130–1141.
  • Peden-Adams M, Keller J, Eudaly J, Berger J, Gilkeson G, Keil D. 2008. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci. 104(1):144–154.
  • Phelps D, Fletcher A, Rodriguez-Nunez I, Balik-Meisner M, Tokarz D, Reif D, Germolec D, Yoder J. 2020. In vivo assessment of respiratory burst inhibition by xenobiotic exposure using larval zebrafish. J Immunotoxicol. 17(1):94–104.
  • Pick E. 2020. Cell-free NADPH oxidase activation assays: A triumph of reductionism. Meth Mol Biol. 2087:325–411.
  • Pierozan P, Jerneren F, Karlsson O. 2018. Perfluorooctanoic acid (PFOA) exposure promotes proliferation, migration, and invasion potential in human breast epithelial cells. Arch Toxicol. 92(5):1729–1739.
  • Pierozan P, Karlsson O. 2018. PFOS induces proliferation, cell-cycle progression, and malignant phenotype in human breast epithelial cells. Arch Toxicol. 92(2):705–716.
  • Reif D, Martin M, Tan S, Houck K, Judson R, Richard A, Knudsen T, Dix D, Kavlock R. 2010. Endocrine profiling and prioritization of environmental chemicals using ToxCast data. Environ Health Perspect. 118(12):1714–1720.
  • Rice P, Aungst J, Cooper J, Bandele O, Kabadi SV. 2020. Comparative analysis of the toxico-logical databases for 6:2 fluorotelomer alcohol (6:2 FTOH) and perfluorohexanoic acid (PFHxA). Food Chem Toxicol. 138:111210.
  • Rincón E, Rocha-Gregg B, Collins S. 2018. A map of gene expression in neutrophil-like cell lines. BMC Genomics. 19(1):573.
  • Ritz C, Baty F, Streibig J, Gerhard D. 2015. Dose-response analysis rsing R. PLOS ONE. 10(12):e0146021.
  • Rockwell C, Turley A, Cheng X, Fields P, Klaassen C. 2013. Acute immunotoxic effects of perfluorononanoic acid (PFNA) in C57BL/6 mice. Clin Exp Pharmacol Physiol. Suppl 4:S4- 002.
  • Rosenmai A, Taxvig C, Svingen T, Trier X, van Vugt-Lussenburg B, Pedersen M, Lesné L, Jégou B, Vinggaard A. 2016. Fluorinated alkyl substances and technical mixtures used in food paper-packaging exhibit endocrine-related activity in vitro. Andrology. 4(4):662–672.
  • Rushing B, Hu Q, Franklin J, McMahen R, Dagnino S, Higgins C, Strynar M, DeWitt J. 2017. Evaluation of the immunomodulatory effects of 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate in C57BL/6 mice. Toxicol Sci. 156:179–189.
  • Shane H, Baur R, Lukomska E, Weatherly L, Anderson S. 2020. Immunotoxicity and allergenic potential induced by topical application of perfluorooctanoic acid (PFOA) in a murine model. Food Chem Toxicol. 136:111114.
  • Sheehan H, Storey G. 1947. An improved method of staining leucocyte granules with Sudan black B. J Pathol Bacteriol. 59(1-2):336.
  • Signorell A. 2021. DescTools: Tools for descriptive statistics. R package. https://andrisignorell. github.io/DescTools/.
  • Siraki A. 2021. The many roles of myeloperoxidase: From inflammation and immunity to bio-markers, drug metabolism, and drug discovery. Redox Biol. 46:102109.
  • Steenland K, Zhao L, Winquist A, Parks C. 2013. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Environ Health Perspect. 121(8):900–905.
  • Sun M, Arevalo E, Strynar M, Lindstrom A, Richardson M, Kearns B, Pickett A, Smith C, Knappe D. 2016. Legacy and emerging perfluoroalkyl substances are important drinking water contaminants in the Cape Fear River watershed of North Carolina. Environ Sci Technol Lett. 3(12):415–419.
  • Tian J, Hong Y, Li Z, Yang Z, Lei B, Liu J, Cai Z. 2021. Immunometabolism-modulation and immunotoxicity evaluation of perfluorooctanoic acid in macrophages. Ecotoxicol Environ Saf. 215:112128.
  • Truong L, Reif D, St Mary L, Geier M, Truong H, Tanguay R. 2014. Multi-dimensional in vivo hazard assessment using zebrafish. Toxicol Sci. 137(1):212–233.
  • Verdon R, Gillies S, Brown D, Henry T, Tran L, Tyler C, Rossi A, Stone V, Johnston H. 2021. Neutrophil activation by nanomaterials in vitro: Comparing strengths and limitations of primary human cells with those of an immortalized (HL-60) cell line. Nanotoxicology. 15(1):1–20.
  • Wang Z, DeWitt J, Higgins C, Cousins I. 2017. A never-ending story of per- and polyfluoroalkyl substances (PFASs)? Environ Sci Technol. 51(5):2508–2518.
  • Wang Z, Yao J, Guo H, Sheng N, Guo Y, Dai J. 2022. Comparative hepatotoxicity of a novel perfluoroalkyl ether sulfonic acid, Nafion byproduct 2 (H-PFMO2OSA), and legacy perfluorooctane sulfonate (PFOS) in adult male mice. Environ Sci Technol. 56(14):10183–10192.
  • Westerfield M. 2007. The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio). 5th Edition. Eugene, OR: University of Oregon Press.
  • Westerman T, Bogomolnaya L, Andrews-Polymenis H, Sheats M, Elfenbein J. 2018. The Salmonella type-3 secretion system-1 and flagellar motility influence the neutrophil respiratory burst. PLOS One. 13(9):e0203698.
  • Williams A, Grulke C, Edwards J, McEachran A, Mansouri K, Baker N, Patlewicz G, Shah I, Wambaugh J, Judson R, et al. 2017. The CompTox chemistry dashboard: A community data resource for environmental chemistry. J Cheminform. 9(1):61.
  • Williams A, Williams A, Lambert J, Thayer K, Dorne J. 2021. Sourcing data on chemical properties and hazard data from the US-EPA CompTox chemicals dashboard: A practical guide for human risk assessment. Environ Intl. 154:106566.
  • Yang Q, Abedi-Valugerdi M, Xie Y, Zhao X, Möller G, Nelson B, DePierre J. 2002. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Intl. Immunopharmacol. 2(2–3):389–397.
  • Yao J, Pan Y, Sheng N, Su Z, Guo Y, Wang J, Dai J. 2020. Novel perfluoroalkyl ether carboxylic acids (PFECAs) and sulfonic acids (PFESAs): Occurrence and association with serum biochemical parameters in residents living near a fluorochemical plant in China. Environ Sci Technol. 54(21):13389–13398.
  • Yu L, Li W, Lv G, Sun G, Yang L, Chen J, Zhou L, Ding Y, Zhang Z, Tang X, et al. 2023. De novo somatic mosaicism of CYBB caused by intronic LINE-1 element insertion resulting in chronic granulomatous disease. J Clin Immunol. 43(1):88–100.
  • Zhang C, McElroy A, Liberatore H, Alexander N, Knappe D. 2022. Nov 4 Stability of per- and polyfluoroalkyl substances in solvents relevant to environmental and toxicological analysis. Environ Sci Technol. 56(10):6103–6112.
  • Zhang G, Roell K, Truong L, Tanguay R, Reif D. 2017. A data-driven weighting scheme for multivariate phenotypic endpoints recapitulates zebrafish developmental cascades. Toxicol Appl Pharmacol. 314:109–117.
  • Zheng L, Dong G, Jin Y, He Q. 2009. Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL/6 mice. Arch Toxicol. 83(7):679–689.
  • Zheng L, Dong G, Zhang Y, Liang Z, Jin Y, He Q. 2011a. Type 1 and Type 2 cytokine imbalance in adult male C57BL/6 mice following a 7-day oral exposure to perfluorooctanesulfonate (PFOS). J Immunotoxicol. 8(1):30–38.
  • Zheng X, Liu H, Shi W, Wei S, Giesy J, Yu H. 2011b. Effects of perfluorinated compounds on development of zebrafish embryos. Environ Sci Pollut Res. 19(7):2498–2505.
  • Zhong Y, Shen L, Ye X, Zhou D, He Y, Zhang H. 2020. Mechanism of immunosuppression in zebrafish (Danio rerio) spleen induced by environmentally relevant concentrations of perfluorooctanoic acid. Chemosphere. 249:126200.